134 related articles for article (PubMed ID: 35373958)
1. In utero myelomeningocele repair and high-risk bladder pattern. a prospective study.
Macedo A; Ottoni SL; Moron A; Cavalheiro S; da Cruz ML
Int Braz J Urol; 2022; 48(4):672-678. PubMed ID: 35373958
[TBL] [Abstract][Full Text] [Related]
2. In utero myelomeningocele repair and incidence of lower urinary tract surgery. Results of a prospective study.
Macedo A; Ottoni SL; Garrone G; Moron A; Cavalheiro S; Leal da Cruz M
J Pediatr Urol; 2021 Dec; 17(6):769-774. PubMed ID: 34452829
[TBL] [Abstract][Full Text] [Related]
3. Comparison of risk of anticholinergic utilization for treatment of neurogenic bladder between in utero or postnatal myelomeningocele repair.
Zaccaria L; Daugherty M; Grant C; Strine AC; Reddy PP; DeFoor WR; Minevich E; Lim FY; VanderBrink BA
J Pediatr Urol; 2021 Aug; 17(4):525.e1-525.e7. PubMed ID: 34074608
[TBL] [Abstract][Full Text] [Related]
4. In utero myelomeningocele repair: The natural history of patients with incontinent pattern (sphincteric deficiency: leakage below 40 CMH20).
Macedo A; Di Migueli RDD; Cavalheiro S; Moron A; da Cruz ML
Neurourol Urodyn; 2020 Nov; 39(8):2373-2378. PubMed ID: 32918741
[TBL] [Abstract][Full Text] [Related]
5. Urological evaluation of patients that had undergone in utero myelomeningocele closure: A prospective assessment at first presentation and early follow-up. Do their bladder benefit from it?
Macedo A; Leal M; Rondon A; Ortiz V; Moron AF; Cavalheiro S
Neurourol Urodyn; 2015 Jun; 34(5):461-4. PubMed ID: 24729268
[TBL] [Abstract][Full Text] [Related]
6. Detrusor Pressures Change with Repeat Filling Cystometry in Myelodysplastic Children with Neurogenic Lower Urinary Tract Dysfunction.
Ergun R; Sekerci CA; Tanidir Y; Atmis B; Gemici A; Yucel S
J Urol; 2021 Feb; 205(2):577-585. PubMed ID: 32897763
[TBL] [Abstract][Full Text] [Related]
7. Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele.
Sager C; Burek C; Corbetta JP; Weller S; Ruiz J; Perea R; Lago E; Gomez Y; Durán V; López JC
J Pediatr Urol; 2017 Jun; 13(3):271.e1-271.e5. PubMed ID: 28215830
[TBL] [Abstract][Full Text] [Related]
8. Categorization of bladder dynamics and treatment after fetal myelomeningocele repair: first 50 cases prospectively assessed.
Leal da Cruz M; Liguori R; Garrone G; Leslie B; Ottoni SL; Carvalheiro S; Moron AF; Ortiz V; Macedo A
J Urol; 2015 May; 193(5 Suppl):1808-11. PubMed ID: 25817149
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Analysis of Bladder Pattern of Patients who Underwent In Utero Versus Postnatal Myelomeningocele Repair.
Parizi JLG; Leal da Cruz M; Andrade MC; Garrone G; Ottoni SL; Cavalheiro S; Moron A; Macedo A
J Urol; 2020 Jan; 203(1):194-199. PubMed ID: 31479395
[TBL] [Abstract][Full Text] [Related]
10. A simple screening tool for an unfavorable bladder in children with myelomeningocele: Is the height to width ratio of the cystogram useful to predict high-pressure bladder?
Kumano Y; Hayashi C; Gohbara A; Yamazaki Y
J Pediatr Urol; 2020 Dec; 16(6):839.e1-839.e5. PubMed ID: 33023850
[TBL] [Abstract][Full Text] [Related]
11. In utero myelomeningocoele repair and urological outcomes: the first 100 cases of a prospective analysis. Is there an improvement in bladder function?
Macedo A; Ottoni SL; Garrone G; Liguori R; Cavalheiro S; Moron A; Leal Da Cruz M
BJU Int; 2019 Apr; 123(4):676-681. PubMed ID: 30548158
[TBL] [Abstract][Full Text] [Related]
12. In utero closure of myelomeningocele does not improve lower urinary tract function.
Lee NG; Gomez P; Uberoi V; Kokorowski PJ; Khoshbin S; Bauer SB; Estrada CR
J Urol; 2012 Oct; 188(4 Suppl):1567-71. PubMed ID: 22917751
[TBL] [Abstract][Full Text] [Related]
13. The timing of primary neurosurgical repair significantly affects neurogenic bladder prognosis in children with myelomeningocele.
Tarcan T; Onol FF; Ilker Y; Alpay H; Simşek F; Ozek M
J Urol; 2006 Sep; 176(3):1161-5. PubMed ID: 16890717
[TBL] [Abstract][Full Text] [Related]
14. Early postnatal bladder function in fetoscopic myelomeningocele repair patients.
Huang GO; Belfort MA; Whitehead WE; Olutoye OO; Castillo J; Castillo H; Ostermaier KK; Koh CJ; Tu DD
J Pediatr Rehabil Med; 2017 Dec; 10(3-4):327-333. PubMed ID: 29125525
[TBL] [Abstract][Full Text] [Related]
15. Age-based risk of end-stage kidney disease in patients with myelomeningocele.
Adams CM; Misseri R; Roth JD; Whittam BM; Guckien ZE; King SJ; Kaefer M; Rink RC; Szymanski KM
J Pediatr Urol; 2023 Apr; 19(2):195.e1-195.e7. PubMed ID: 36628830
[TBL] [Abstract][Full Text] [Related]
16. Long-term urological impact of fetal myelomeningocele closure.
Clayton DB; Tanaka ST; Trusler L; Thomas JC; Pope JC; Adams MC; Brock JW
J Urol; 2011 Oct; 186(4 Suppl):1581-5. PubMed ID: 21862080
[TBL] [Abstract][Full Text] [Related]
17. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
[TBL] [Abstract][Full Text] [Related]
18. Prenatal myelomeningocele repair: Do bladders better?
Horst M; Mazzone L; Schraner T; Bodmer C; Möhrlen U; Meuli M; Gobet R
Neurourol Urodyn; 2017 Aug; 36(6):1651-1658. PubMed ID: 27862250
[TBL] [Abstract][Full Text] [Related]
19. Need for botulinum toxin injection and bladder augmentation after isolated bladder outlet procedure in pediatric patients with myelomeningocele.
Smith MC; Strine AC; DeFoor WR; Minevich E; Noh P; Sheldon CA; Reddy PP; VanderBrink BA
J Pediatr Urol; 2020 Feb; 16(1):32.e1-32.e8. PubMed ID: 31839471
[TBL] [Abstract][Full Text] [Related]
20. Initial urologic management of myelomeningocele.
Snodgrass WT; Adams R
Urol Clin North Am; 2004 Aug; 31(3):427-34, viii. PubMed ID: 15313052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
